Keywords: CEST / APT / NOE, CEST & MT, bone and soft tissue sarcoma
Motivation: Evaluating the response to chemotherapy based on volume changes is often difficult in bone and soft tissue sarcomas; therefore, new molecular imaging techniques are required.
Goal(s): To investigate whether amide proton transfer (APT) imaging combined with apparent diffusion coefficient (ADC) accurately reflects treatment efficacy in bone and soft tissue sarcomas.
Approach: An MRI was performed before and after chemotherapy in 12 patients who received preoperative chemotherapy. Tumor volume, APT, and ADC were compared before and after treatment and correlated with postoperative pathology specimens.
Results: Only APT imaging with ADC correction correctly reflected the effect of preoperative chemotherapy.
Impact: The present study demonstrates that a new molecular imaging technique can accurately determine the efficacy of chemotherapy for bone and soft tissue sarcomas. This will help to determine the optimal course of treatment and improve patient prognosis.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords